A Fund Methodology That Adds Value
This fund follows a methodology that leads it to allocate heavily to Attractive-or-better rated stocks.
Matt Shuler, Investment Analyst II
DENTSPLY SIRONA
Matt Shuler, Investment Analyst II
Featured Stocks in August’s Most Attractive/Most Dangerous Model Portfolios
20 new stocks make our Most Attractive list this month, and 21 new stocks fall onto the Most Dangerous list this month.
Sam McBride
Position Close Update: Dentsply Sirona (XRAY)
While XRAY’s fundamentals remain weak, the growth expectations implied by its valuation have become less unrealistic after the large price decline.
Kyle Guske II, Senior Investment Analyst, MBA
Podcast: Why Dentsply Sirona is in the Danger Zone
CEO David Trainer sat down with Chuck Jaffe of Money Life and to talk about our Danger Zone pick this past week: Dentsply Sirona (XRAY).
Kyle Guske II, Senior Investment Analyst, MBA
An Example of Misaligned Incentives Leading to a Bad Outcome
This firm's move to bolster growth via a large acquisition recently resulted in the ouster of top executives. Despite pending new leadership, investors remain at risk given the firm's falling profits, lagging margins and overvalued stock price.
Kyle Guske II, Senior Investment Analyst, MBA